ALPS ADVISORS INC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,517,680
-12.1%
120,810
+1.1%
0.02%
-16.0%
Q2 2023$2,862,887
+42.3%
119,536
+11.8%
0.02%
+38.9%
Q1 2023$2,011,538
+15.2%
106,883
-2.6%
0.02%
+12.5%
Q4 2022$1,746,488
+20.8%
109,704
+24.1%
0.02%
+14.3%
Q3 2022$1,446,000
+8.6%
88,366
-6.5%
0.01%
+7.7%
Q2 2022$1,331,000
-66.8%
94,484
-43.0%
0.01%
-70.5%
Q1 2022$4,013,000
-7.6%
165,681
-10.9%
0.04%
-10.2%
Q4 2021$4,342,000
+32.8%
186,044
-5.5%
0.05%
+53.1%
Q3 2021$3,270,000
-36.2%
196,894
-6.3%
0.03%
-28.9%
Q2 2021$5,126,000
-32.6%
210,179
-0.5%
0.04%
-23.7%
Q3 2019$7,600,000
-5.5%
211,163
-29.8%
0.06%
-1.7%
Q2 2019$8,039,000
+77.0%
300,750
+149.5%
0.06%
+87.5%
Q3 2017$4,541,000
+47.8%
120,544
+9.4%
0.03%
+52.4%
Q2 2017$3,072,000
-14.2%
110,163
+5.7%
0.02%
-16.0%
Q1 2017$3,582,000
+6.7%
104,195
-10.5%
0.02%0.0%
Q4 2016$3,357,000
-30.9%
116,391
-23.8%
0.02%
-37.5%
Q3 2016$4,856,000
+2.5%
152,658
+14.8%
0.04%
-13.0%
Q4 2015$4,739,000
-90.9%
132,936
-15.7%
0.05%
-16.4%
Q3 2015$52,133,000
+1150.8%
157,645
+58.4%
0.06%
+52.8%
Q2 2015$4,168,000
+158.1%
99,533
+100.8%
0.04%
+176.9%
Q1 2015$1,615,00049,5650.01%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders